Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: Attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin

Molecular and Cellular Biochemistry

Volumn 178, Issue 1-2, 1998, Pages 59-68

  Chaudhary, Lala R ^a   Avioli, Louis V ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

cAMP; ERK1 and ERK2; Human bone marrow stromal cells; MAP kinase; Normal human osteoblasts; Parathyroid hormone

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL ENZYME; CYCLIC AMP; FORSKOLIN; GROWTH FACTOR; HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; MYELIN BASIC PROTEIN; NEUROTRANSMITTER; PARATHYROID HORMONE; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOGENESIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA CELL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; STROMA CELL;

ANIMALS; BONE MARROW CELLS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; CYCLIC AMP; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; FORSKOLIN; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOBLASTS; PEPTIDE FRAGMENTS; PLATELET-DERIVED GROWTH FACTOR; RATS; STROMAL CELLS; TERIPARATIDE;

EID: 0031888597     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006807221545     Document Type: Article

References (50)

1. Hock JM, Centrella M, Canalis E: Insulin-like growth factor I has independent effect on bone matrix formation and cell replication. Endocrinol 122: 254-260, 1988
2. Wergedal JE, Mohan S, Lundy M, Baylink DJ: Skeletal growth factor and other factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. J Bone Miner Res 5: 179-186, 1990
3. Robinson D, Bab I, Nevo Z: Osteogenic growth peptide regulates proliferation and osteogenic maturation of human and rabbit bone marrow stromal cells. J Bone Miner Res 10: 690-696, 1995
4. Globus RK, Patterson-Buckendahl P, Gospodarowicz D: Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor β. Endocrinol 123: 98-105, 1988
5. Rodan SB, Wesolowski G, Thomas KA, Yoon K, Rodan GA: Effects of acidic and basic fibroblast growth factors on osteoblastic cells. Connect Tissue Res 20: 283-288, 1989
6. Mayahara H, Ito T, Nagai H, Miyajima H, Tsukuda R, Taketomi S, Mizoguchi J, Kato K: In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9: 73-80, 1993
7. Nakamura T, Hanada K, Tamura M, Shibanushi T, Nigi H, Tagawa M, Fukumoto S, Matsumoto T: Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinol 136: 1276-1284, 1995
8. Zhang L, Leeman E, Carnes DC, Graves DT: Human osteoblasts synthesize and respond to platelet-derived growth factor. Am J Physiol 261: C348-C354, 1991
9. Ahn NG, Seger R, Krebs EG: The mitogen-activated protein kinase activator. Curr Opin Cell Biol 4: 992-999, 1992
10. Pelech SL, Sanghera JS: MAP kinases: Charting the regulatory pathways. Science 257: 1355-1356, 1992
11. Blenis J: Signal transduction via the MAP kinases. Proceed at your own RSK. Proc Natl Acad Sci USA 90: 5889-5892, 1993
12. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556, 1993
13. Cobb MH, Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995
14. Anderson NG, Maller J, Tonks NK, Sturgill TW: Requirement for integration of signals from two distinct phosphorylation pathway for activation of MAP kinase. Nature (London) 343: 651-653, 1990
15. Seger R, Ahn NG, Boulton TG, Yancopoulos G, Panayotatos N, Radziejewska E, Ericsson L, Bratlien RL, Cobb MH, Krebs EG: Microtubule-associated protein 2 kinases, ERK1 and ERK2, undergo autophosphorylation on both tyrosine and threonine residues: Implications for their mechanism of activation. Proc Natl Acad Sci USA 88: 6142-6146, 1991
16. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePito RA, Panayotatos N, Cobb MH, Yancopoulos GD: ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663-675, 1991
17. Rossomando AJ, Sanghera JS, Marsden LA, Weber MJ, Pelech SL, Sturgill TW: Biochemical characterization of a family of serine/ threonine protein kinases regulated by tyrosine and serine/threonine phosphorylations. J Biol Chem 266: 20270-20275, 1991
18. Sevetson BR, Kong X, Lawrence Jr. JC: Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA 90: 10305-10309, 1993
19. Chaudhary LR, Avioli LV: Regulation of interleukin-8 gene expression by interleukin-1β, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells. J Biol Chem 271: 16591-16596,1996
20. Robey PG, Termine JD: Human bone cells in vitro. Calcif Tissue Int 37: 453-460, 1985
21. Rifas L, Halstead LR, Week WA, Avioli LV, Welgus HG: Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinse but not interstitial collagenase as major cellular products. J Clin Invest 84: 248-254, 1989
22. Kameshita I, Fujisawa H: A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal Biochem 183: 139-143, 1989
23. Chao T-SO, Byron KL, Lee K-M, Villereal M, Rosner MR: Activation of MAP kinases by calcium-dependent and calcium-dependent pathways: Stimulation by thapsigargin and epidermal growth factors. J Biol Chem 267: 19876-19883, 1992
24. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
25. Cook SJ, McCormick F: Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069-1072, 1993
26. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW: Inhibition of the EGF-activated MAP kinase signalling pathway by adenosine-3 ,5 -monophosphate. Science 262: 1065-1069, 1993
27. ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J 12: 4211-4220, 1993
28. Graves LM, Bornfeldt KE, Raines EW, Potts BC, MacDonald SG, Ross R, Krebs EG: Protein kinase A antagonizes platelet-derived growth factor-induced signalling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci USA 90: 10300-10304, 1993
29. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, Leslie CC, Krebs EG: Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem 271: 505-511, 1996
30. Frodin M, Peraldi P, van Obberghen E: Cyclic AMP activates the mitogen-activated protein kinase cascade in PC 12 cells. J Biol Chem 269: 6207-6214, 1994
31. Boulten TG, Cobb MH: Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. Cell Regulation 2:357-371, 1991
32. Verheijen MHG, Defize HK: Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase A-dependent pathway. Endocrinology 136: 3331-3337, 1995
33. Zhang W, Dziak RM, Aletta JM: EGF-mediated phosphorylation of extracellular signal-regulated kinases in osteoblastic cells. J Cell Physiol 162: 348-358, 1995
34. Chabre O, Cornillon F, Bottari SP, Chambaz EM, Vilgrain I: Hormonal regulation of mitogen-activated protein kinase activity in bovine adrenocortical cells: Cross-talk between phosphoinositides, adenosine 3 ,5 -monophosphate, and tyrosine kinase receptor pathways. Endocrinology 136: 956-964, 1995
35. Siddhanti SR, Hartle II JE, Quarles LD: Forskolin inhibits protein kinase C-induced mitogen-activated protein kinase activity in MC3T3-E1 osteoblasts. Endocrinology 136: 4834-4841, 1995
36. Partridge NC, Opie AL, Opie RT, Martin TJ: Inhibitory effects of parathyroid hormones on growth of osteogenic sarcoma cells. Calcif Tissue Int 37: 519-525, 1985
37. Reid IR, Civitelli R, Avioli LV, Hruska KA: Parathyroid hormone derepresses cytosolic pH and DNA synthesis in osteoblastic cells. Am J Physiol 255: E9-E15, 1988
38. Fang MA, Kubuju DA, Hahn TJ: The effects of prostaglandin E2, parathyroid hormone, and epidermal growth factor on mitogenesis, signalling, and primary response gene in UMR-106-01 osteoblast-like cells. Endocrinology 131: 2113-2119, 1992
39. Partridge NC, Dickson CA, Kopp K, Teitelbaum SL, Crouch EC, Kahn AJ: Parathyroid hormone inhibits collagen synthesis at both nucleic acid and protein levels in rat osteogenic sarcoma cells. Mol Endocrinol 3: 232-239, 1989
40. Ohta S, Shigeno C, Yamamoto I, Okumura H, Lee K, Uneno S, Konishi J, Yamamoto T: Parathyroid hormone down-regulates the epidermal growth factor receptors in clonal osteoblastic mouse calvarial cells, MC3T3-E1: possible mediation by adenosine 3 ,5 -cyclic monophosphate. Endocrinology 124: 2419-2426, 1989
41. McKenzie FR, Pouyssegur J: cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition: cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases. J Biol Chem 271: 13476-13483, 1996
42. Evans DB, Hipskind RA, Bilbe G: Analysis of signalling pathways used by parathyroid hormone to activate the c-fos gene in human SaOS2 osteoblast-like cells. J Bone Miner Res 11: 1066-1074, 1996
43. Haystead TAJ, Haystead CMM, Hu C, Lin T-A, Lawrence Jr. JC: Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. J Biol Chem 269: 23185-23191, 1994
44. Lin T-A, Kong X, Haystead TAJ, Pause A, Belsham GJ, Sonenberg N, Lawrence Jr. JC: PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266: 653-656, 1994
45. Pause A, Belsham GJ, Gingras A-C, Donze O, Lin T-A, Lawrence Jr. JC, Sonenberg N: Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5 -cap function. Nature 371: 762-767, 1994
46. Graves LM, Bornfeldt KE, Argast GM, Krebs EG, Kong X, Lin T-A, Lawrence Jr. JC: cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator of PHAS-I in aortic smooth cells. Proc Natl Acad Sci USA 92: 7222-7226, 1995
47. Hunter T: Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signalling. Cell 80: 225-236, 1995
48. Lin T-A, Kong X, Saltiel AL, Blackshear PJ, Lawrence Jr. JC: Control of PHAS-I by insulin in 3T3-L1 adipocytes: synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway. J Biol Chem 270: 18531-18538, 1995
49. Von Manteuffel SR, Gingras A-C, Ming X-F, Sonenberg N, Thomas G: 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. Proc Natl Acad Sci 93: 4076-4080, 1996
50. Chaudhary LR, Avioli LV: Identification and regulation of PHAS-I protein by PDGF-BB and basic FGF in normal human osteoblastic cells. J Bone Miner Res 11 (Suppl. 1): S176, 1996